Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.

Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.

Item
http://www.wikidata.org/entity/Q37871843
Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey.The role of infection in the pathogenesis of cardiovascular disease.Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Macrolide antibiotics: current and future uses.Advances in the management of Chlamydia pneumoniae infections.Development potential of rifalazil and other benzoxazinorifamycins.Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies.Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trialHigh frequency of Chlamydophila pneumoniae infections: patients with peripheral arterial disease and those with risk factors for cardiovascular diseases compared to normal subjects.Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.Continuous, quantitative monitoring of roxithromycin in human saliva by flow injection chemiluminescence analysis.Periodontitis and atherogenesis: causal association or simple coincidence?
P2860

Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.

Item
http://www.wikidata.org/entity/Q37871843
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@en
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@nl
type
label
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@en
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@nl
prefLabel
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@en
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Roxithromycin treatment preven ...... ind, placebo-controlled trial.
@en
P2093
P304
P31
P356
10.1161/01.CIR.0000017862.08503.15
P407
P433
P478
P577
P5875
P698
P921